Citation Impact
Citing Papers
Hepcidin Regulates Cellular Iron Efflux by Binding to Ferroportin and Inducing Its Internalization
2004 StandoutScience
Immune Control of Tuberculosis by IFN-γ-Inducible LRG-47
2003 StandoutScience
Update on prevention, diagnosis, and treatment of chronic hepatitis B: AASLD 2018 hepatitis B guidance
2018 Standout
Ligand-tethered lipid nanoparticles for targeted RNA delivery to treat liver fibrosis
2023 StandoutNobel
Hepatitis C virus infection acquired in childhood
2007
Management of hepatitis B
2007
Regulation of Type II Transmembrane Serine Proteinase TMPRSS6 by Hypoxia-inducible Factors
2010 StandoutNobel
The molecular basis of hepcidin-resistant hereditary hemochromatosis
2009
Dysmetabolic Hyperferritinemia: All Iron Overload Is Not Hemochromatosis
2015
Thiazolidinediones
2004 Standout
Iron homeostasis: insights from genetics and animal models
2000
Clinical and Histologic Spectrum of Nonalcoholic Fatty Liver Disease Associated With Normal Alt Values
2003
Risk of severe liver disease in nonalcoholic fatty liver disease with normal aminotransferase levels: A role for insulin resistance and diabetes
2008
Pathogenesis and treatment of anaemia of chronic disease
2002
Intraphagosomal Mycobacterium tuberculosis Acquires Iron from Both Extracellular Transferrin and Intracellular Iron Pools
2002
Limitations of non-invasive tests for assessment of liver fibrosis
2020
Hepatocellular carcinoma
2018 Standout
The Global Impact of Hepatic Fibrosis and End-Stage Liver Disease
2008
Rising Incidence of Hepatocellular Carcinoma in the United States
1999 Standout
Elevated Serum Alanine Aminotransferase and γ-Glutamyltransferase and Mortality in the United States Population
2008
Increased Angiogenesis Protects against Adipose Hypoxia and Fibrosis in Metabolic Disease-resistant 11β-Hydroxysteroid Dehydrogenase Type 1 (HSD1)-deficient Mice
2011 StandoutNobel
Gender Differences in Healthy Ranges for Serum Alanine Aminotransferase Levels in Adolescence
2011
Magnetic resonance spectroscopy to measure hepatic triglyceride content: prevalence of hepatic steatosis in the general population
2004
Carotid Artery Intima-media Thickness in Nonalcoholic Fatty Liver Disease
2008
The clinical features, diagnosis and natural history of nonalcoholic fatty liver disease
2004
Hereditary Hemochromatosis — A New Look at an Old Disease
2004
Risk Factors for Perinatal Transmission of Hepatitis C Virus (HCV) and the Natural History of HCV Infection Acquired in Infancy
2005
The metabolic syndrome
2010 Standout
The gene TFR2 is mutated in a new type of haemochromatosis mapping to 7q22
2000
Disappointing sensitivity of endoscopic markers for villous atrophy in a high-risk population: implications for celiac disease diagnosis during routine endoscopy
2001
Coeliac disease
2003
Balancing Acts
2004 Standout
Hepatocellular carcinoma
2012 Standout
Prevalence of Hepatic Steatosis in An Urban Population in the United States: Impact of Ethnicity
2004 Standout
Interferon Alpha-2b and Ribavirin for Patients with Chronic Hepatitis C and Normal ALT
2004
Long-Term Course of Chronic Hepatitis C in Children: From Viral Clearance to End-Stage Liver Disease
2008
Design and Endpoints of Clinical Trials in Hepatocellular Carcinoma
2008
Lamivudine for Patients with Chronic Hepatitis B and Advanced Liver Disease
2004 Standout
Diagnosis, management, and treatment of hepatitis C: An update # † ‡
2008 Standout
Aminotransferase Levels and 20-Year Risk of Metabolic Syndrome, Diabetes, and Cardiovascular Disease
2008
Celiac Disease
2007 Standout
Adipocyte iron regulates adiponectin and insulin sensitivity
2012
From NAFLD in clinical practice to answers from guidelines
2013
Rosiglitazone for Nonalcoholic Steatohepatitis: One-Year Results of the Randomized Placebo-Controlled Fatty Liver Improvement With Rosiglitazone Therapy (FLIRT) Trial
2008
Diabetic Retinopathy
2012 Standout
Hepatitis C and Pregnancy
2006
Two to Tango: Regulation of Mammalian Iron Metabolism
2010 Standout
Autosomal-dominant hemochrom-atosis is associated with a mutation in the ferroportin (SLC11A3) gene
2001
The metabolic syndrome
2005 Standout
Clinical Spectrum and Histopathologic Features of Chronic Hepatitis C Infection in Children
2007
Clinical, histological, and virological features of hepatitis C virus carriers with persistently normal or abnormal alanine transaminase levels
1997
A role of PIEZO1 in iron metabolism in mice and humans
2021 StandoutNobel
Role of the Ferroportin Iron-Responsive Element in Iron and Nitric Oxide Dependent Gene Regulation
2002
Evolving challenges in hepatic fibrosis
2010
Clinical management of HCV carriers with normal aminotransferase levels
2003
Parkinson's disease
2015 Standout
Nonalcoholic Fatty Liver Disease and Hepatocellular Carcinoma: A Weighty Connection
2010
Meta‐analysis: surveillance with ultrasound for early‐stage hepatocellular carcinoma in patients with cirrhosis
2009
Nonalcoholic Steatohepatitis: Summary of An Aasld Single Topic Conference
2003 Standout
Transferrin Receptor Induction by Hypoxia
1999
Chronic hepatitis B
2007 Standout
Iron regulation by hepcidin
2013
Lipocalin 2 mediates an innate immune response to bacterial infection by sequestrating iron
2004 StandoutNature
Reactive oxygen species (ROS) homeostasis and redox regulation in cellular signaling
2012 Standout
Management of hepatitis C
2003
Estimation of the Healthy Upper Limits for Serum Alanine Aminotransferase in Asian Populations With Normal Liver Histology
2009
Peginterferon alfa-2a (40 kilodaltons) and ribavirin in patients with chronic hepatitis C and normal aminotransferase levels
2004
Chronic hepatitis B: Update 2009 #
2009 Standout
Haemochromatosis
2018
Hypoxia Rescues Frataxin Loss by Restoring Iron Sulfur Cluster Biogenesis
2019 StandoutNobel
Prevalence of non-alcoholic fatty liver disease and its association with cardiovascular disease in patients with type 1 diabetes
2010
Optimization of imaging diagnosis of 1–2cm hepatocellular carcinoma: An analysis of diagnostic performance and resource utilization
2010
Expression pattern and localization of alpha-synuclein in the human enteric nervous system
2012
Hematopoietic Stem-Cell Transplantation
2006 Standout
The role of endogenous heme synthesis and degradation domain cysteines in cellular iron-dependent degradation of IRP2
2003
Seroprevalence, correlates, and characteristics of undetected coeliac disease in England
2003
Positional cloning of zebrafish ferroportin1 identifies a conserved vertebrate iron exporter
2000 StandoutNature
Genetic variation in IL28B predicts hepatitis C treatment-induced viral clearance
2009 StandoutNature
Hepatitis C and hepatocellular carcinoma
1997
Long-Term Follow-Up of Patients With Nonalcoholic Fatty Liver
2008
Risk of Cardiovascular Disease in Patients with Nonalcoholic Fatty Liver Disease
2010 Standout
Effect of iron treatment on circulating cytokine levels in ESRD patients receiving recombinant human erythropoietin
2003
Iron and immunity: a double‐edged sword
2002
Genes that modify the hemochromatosis phenotype in mice
2000
What We Talk About When We Talk About Fat
2014 Standout
Suspected Nonalcoholic Fatty Liver Disease and Mortality Risk in a Population-Based Cohort Study
2008
SAFETY Study: Alanine Aminotransferase Cutoff Values Are Set Too High for Reliable Detection of Pediatric Chronic Liver Disease
2010
The management of HCV infected pregnant women and their children European paediatric HCV network
2005
Crystal Structure of the Hepatitis C Virus NS3 Protease Domain Complexed with a Synthetic NS4A Cofactor Peptide
1996 StandoutNobel
Repertoires of Autophagy in the Pathogenesis of Ocular Diseases
2015 Standout
Chronic Hepatitis C in Patients With Persistently Normal Alanine Transaminase Levels
2006
Elevated alanine aminotransferase levels predict mortality from cardiovascular disease and diabetes in Koreans
2008
Utility in Clinical Practice of Immunoglobulin A Anti-Tissue Transglutaminase Antibody for the Diagnosis of Celiac Disease
2006
Hypoxia-inducible Factor-1 Deficiency Results in Dysregulated Erythropoiesis Signaling and Iron Homeostasis in Mouse Development
2006 StandoutNobel
Iron‐dependent regulation of the divalent metal ion transporter
2001
Disorders of Iron Metabolism
1999 Standout
Genetic ablations of iron regulatory proteins 1 and 2 reveal why iron regulatory protein 2 dominates iron homeostasis
2004
Chronic hepatitis C with normal aminotransferase levels
2004
Endoscopy in celiac disease
2005
Pioglitazone, Vitamin E, or Placebo for Nonalcoholic Steatohepatitis
2010 Standout
The Prevalence and Etiology of Elevated Aminotransferase Levels in The United States
2003
Hepatocellular Carcinoma
2011 Standout
Lysosome-targeting chimaeras for degradation of extracellular proteins
2020 StandoutNatureNobel
Carriers of Inactive Hepatitis B Virus Are Still at Risk for Hepatocellular Carcinoma and Liver-Related Death
2010
A 24‐week course of high‐dose interferon‐α plus ribavirin for Taiwanese chronic hepatitis C patients with persistently normal or near‐normal alanine aminotransferase levels
2006
Non-alcoholic fatty liver disease is independently associated with an increased prevalence of chronic kidney disease and retinopathy in type 1 diabetic patients
2010
Up-regulation of Apoptosis Inhibitory Protein IAP-2 by Hypoxia
2001 StandoutNobel
Upper Limits of Normal for Alanine Aminotransferase Activity in the United States Population
2011
A mutation in SLC11A3 is associated with autosomal dominant hemochromatosis
2001
Anemia of Chronic Disease
2005 Standout
Iron Regulatory Proteins: From Molecular Mechanisms to Drug Development
2010
Diagnosis and Management of the Metabolic Syndrome
2005 Standout
Hepatocellular Carcinoma
2019 Standout
AASLD guidelines for treatment of chronic hepatitis B
2015
Transferrin receptor 1 in cancer: a new sight for cancer therapy.
2018
End-stage renal disease and hepatitis C infection: comparison of alanine aminotransferase levels and liver histology in patients with and without renal damage
2007
Novel role of phosphorylation in Fe–S cluster stability revealed by phosphomimetic mutations at Ser-138 of iron regulatory protein 1
1998
Clinical iron deficiency disturbs normal human responses to hypoxia
2016 StandoutNobel
Physiology of iron transport and the hemochromatosis gene
2002
The hemochromatosis C282Y allele: a risk factor for hepatic veno-occlusive disease after hematopoietic stem cell transplantation
2005
Adaptive and Maladaptive Cardiorespiratory Responses to Continuous and Intermittent Hypoxia Mediated by Hypoxia-Inducible Factors 1 and 2
2012 StandoutNobel
Age‐ and Sex‐related Reference Ranges of Alanine Aminotransferase Levels in Children: European Paediatric HCV Network
2009
Repression of gene expression by oxidative stress
1999
Prevalence of Nonalcoholic Fatty Liver Disease and Its Association With Cardiovascular Disease Among Type 2 Diabetic Patients
2007
Cytokine-mediated regulation of iron transport in human monocytic cells
2003
Pentoxifylline for the treatment of non-alcoholic steatohepatitis: a randomized controlled trial
2011
Imaging for the diagnosis of hepatocellular carcinoma: A systematic review and meta‐analysis
2017
Iron and the anemia of chronic disease.
2002
Zip14 (Slc39a14) mediates non-transferrin-bound iron uptake into cells
2006
Human Fatty Liver Disease: Old Questions and New Insights
2011 StandoutScience
Updated thresholds for serum alanine aminotransferase level in a large‐scale population study composed of 34 346 subjects
2012
Iron Release From Human Monocytes After Erythrophagocytosis In Vitro: An Investigation in Normal Subjects and Hereditary Hemochromatosis Patients
1998
Hereditary iron overload and African Americans
1996
Transient elastography compared to serum markers to predict liver fibrosis in a cohort of C hinese patients with chronic hepatitis B
2014
Understanding iron homeostasis through genetic analysis of hemochromatosis and related disorders
2005
Systemic Iron Homeostasis and the Iron-Responsive Element/Iron-Regulatory Protein (IRE/IRP) Regulatory Network
2008
Generation and Detection of Reactive Oxygen Species in Photocatalysis
2017 Standout
Nonalcoholic Fatty Liver Disease
2015 Standout
Autosomal-dominant hemochrom-atosis is associated with a mutation in the ferroportin (SLC11A3) gene
2001
Regulation of ferritin genes and protein
2002
Fast detection of liver fibrosis with collagen-binding single-nanometer iron oxide nanoparticles via T 1 -weighted MRI
2023 StandoutNobel
Hepatitis C in Children
2006
TIM-2 is expressed on B cells and in liver and kidney and is a receptor for H-ferritin endocytosis
2005
HFE gene knockout produces mouse model of hereditary hemochromatosis
1998
HFE Genotype in Patients with Hemochromatosis and Other Liver Diseases
1999
Works of Dario Conte being referenced
Nitric Oxide Reduces Nontransferrin–Bound Iron Transport in Hepg2 Cells
1999
Transient elastography assessment of the liver stiffness dynamics during acute hepatitis B
2010
Effect of the A736V TMPRSS6 polymorphism on the penetrance and clinical expression of hereditary hemochromatosis
2012
Hereditary Hemochromatosis in Adults without Pathogenic Mutations in the Hemochromatosis Gene
1999
Reevaluation of duodenal endoscopic markers in the diagnosis of celiac disease
2000
Preferential activation of iron regulatory protein‐2 in cell lines as a result of higher sensitivity to iron
1999
Cerebellar degeneration and hearing loss in a patient with idiopathic myenteric ganglionitis
2005
Accuracy of Ultrasonography, Spiral CT, Magnetic Resonance, and Alpha-Fetoprotein in Diagnosing Hepatocellular Carcinoma: A Systematic Review. CME
2006
Transferrin Receptor 1 (TfR1) and Putative Stimulator of Fe Transport (SFT) Expression in Iron Deficiency and Overload: An Overview
2002
Tissue transglutaminase antibodies in patients with end-stage heart failure
2002
Prevalence and clinical course of chronic hepatitis C virus (HCV) infection and rate of HCV vertical transmission in a cohort of 15,250 pregnant women
2000
Duodenal ferritin synthesis in genetic hemochromatosis
1995
Severe Liver Fibrosis or Cirrhosis: Accuracy of US for Detection—Analysis of 300 Cases
2003
Oxidative Stress–Mediated Down–Regulation of Rat Hydroxyacid Oxidase 1, A Liver–Specific Peroxisomal Enzyme
2003
Etiology-related determinants of liver stiffness values in chronic viral hepatitis B or C
2010
Surival and Prognostic Factors in 212 Italian Patients With Genetic Hemochromatosis
1992
Age at infection affects the long-term outcome of transfusion-associated chronic hepatitis C
2002
Nitric Oxide–Mediated Induction of Ferritin Synthesis in J774 Macrophages by Inflammatory Cytokines: Role of Selective Iron Regulatory Protein-2 Downregulation
1998
Nitric Oxide–Mediated Induction of Ferritin Synthesis in J774 Macrophages by Inflammatory Cytokines: Role of Selective Iron Regulatory Protein-2 Downregulation
1998
Comparable frequency of hepatocellular carcinoma in cirrhosis of different aetiology
1994
Iron regulatory proteins 1 and 2 in human monocytes, macrophages and duodenum: expression and regulation in hereditary hemochromatosis and iron deficiency.
2006
Inappropriately High Iron Regulatory Protein Activity in Monocytes of Patients With Genetic Hemochromatosis
1997
Saturability of Hepatic Iron Deposits in Genetic Hemochromatosis
1992
Prevalence of hypertransaminasemia in adult celiac patients and effect of gluten-free diet
1995
Hepatitis C virus RNA and liver histology in blood donors reactive to a single antigen by second-generation recombinant immunoblot assay
1995
Response of Monocyte Iron Regulatory Protein Activity to Inflammation: Abnormal Behavior in Genetic Hemochromatosis
1998
Updated Definitions of Healthy Ranges for Serum Alanine Aminotransferase Levels
2002
Haemochromatosis in patients with beta-thalassaemia trait
2000
Haemochromatosis in patients with β‐thalassaemia trait
2000